FDA DEVICE FACTS
Benchmark BMX96 Access System
Penumbra, Inc.
FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。
Indications for use
The Benchmark BMX96 System is indicated for the introduction of interventional devices into the peripheral, coronary, and neuro vasculature. Comparison of Technological Characteristics with the Predicate Device
The subject device Benchmark BMX96 System has similar technological characteristics to the previously cleared predicate device. At a high level, the subject and predicate devices are based on the following same technological elements:
• Delivery Catheter dimensions (outer diameter (OD), maximum effective length, distal flexible length)
• Delivery Catheter tip shapes
• Sterilization method (EO)
• 36-month shelf life The following technological differences exist between the subject and predicate devices:
• Stainless steel hypotube shaft reinforcement (replaced braided coil reinforcement)
• Catheter Inner Diameter (0.096 in.)
• Shorter effective length options
• Slightly longer hydrophilic coating length
• Modified catheter extrusions to include additional polyurethane and polyether block amide materials
• Dilator OD, length
Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。
OFFICIAL FDA SOURCES
FDA Record and Public Document Status
Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。